Corrigendum: Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life

• Meriem Attaf,
• Meriem Attaf,
• Julia Roider,
• Julia Roider,
• Julia Roider,
• Julia Roider,
• Amna Malik,
• Cristina Rius Rafael,
• Cristina Rius Rafael,
• Garry Dolton,
• Garry Dolton,
• Andrew J. Prendergast,
• Andrew J. Prendergast,
• Andrew J. Prendergast,
• Alasdair Leslie,
• Alasdair Leslie,
• Thumbi Ndung’u,
• Thumbi Ndung’u,
• Thumbi Ndung’u,
• Thumbi Ndung’u,
• Thumbi Ndung’u,
• Henrik N. Kløverpris,
• Henrik N. Kløverpris,
• Andrew K. Sewell,
• Andrew K. Sewell,
• Philip J. Goulder,
• Philip J. Goulder

Affiliations

Meriem Attaf

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Meriem Attaf

Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom

Julia Roider

Human Immunodeficiency Virus Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Julia Roider

Africa Health Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Julia Roider

German Centre for Infection Research, Munich, Germany

Julia Roider

Department of Infectious Diseases, Ludwig-Maximilians-University, Munich, Germany

Amna Malik

Department of Paediatrics, University of Oxford, Oxford, United Kingdom

Cristina Rius Rafael

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Cristina Rius Rafael

Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom

Garry Dolton

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Garry Dolton

Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom

Andrew J. Prendergast

Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe

Andrew J. Prendergast

Centre for Genomics and Child Health, Blizard Institute, Queen Mary University of London, London, United Kingdom

Andrew J. Prendergast

0Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

Alasdair Leslie

Africa Health Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Alasdair Leslie

1Infection and Immunity, University College London, London, United Kingdom

Thumbi Ndung’u

Human Immunodeficiency Virus Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Thumbi Ndung’u

Africa Health Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Thumbi Ndung’u

1Infection and Immunity, University College London, London, United Kingdom

Thumbi Ndung’u

2The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, United States

Thumbi Ndung’u

3Virology and Immunology, Max Planck Institute for Infection Biology, Berlin, Germany

Henrik N. Kløverpris

Africa Health Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

Henrik N. Kløverpris

1Infection and Immunity, University College London, London, United Kingdom

Andrew K. Sewell

Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Andrew K. Sewell

Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom

Philip J. Goulder

Department of Paediatrics, University of Oxford, Oxford, United Kingdom

Philip J. Goulder

2The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, United States